railway stocks us-Backed by SEC-compliant security protocols and 24/7 market support, we don’t just let you trade U.S. stocks—we empower you to invest with confidence, clarity, and a competitive edge that sets you apart..... 
In the dynamic world of healthcare, investing in the right stocks can yield significant returns. As we delve into 2023, several health stocks in the US have emerged as strong contenders. This article highlights the top five US health stocks to keep an eye on this year.
1. Johnson & Johnson (JNJ)
As one of the most renowned healthcare companies, Johnson & Johnson (JNJ) has a diverse portfolio of products and services. From pharmaceuticals to consumer healthcare, JNJ has a strong presence in various segments of the healthcare industry. Its commitment to innovation and research has made it a market leader.
Case Study: In 2022, JNJ acquired Actelion, a Swiss biopharmaceutical company, for $30 billion. This acquisition significantly expanded JNJ's portfolio of rare disease treatments.
2. Pfizer Inc. (PFE)
Pfizer Inc. is another giant in the healthcare industry, known for its groundbreaking research and development. The company's vaccine for COVID-19, Pfizer-BioNTech, played a crucial role in combating the pandemic. With a strong pipeline of new drugs and partnerships, Pfizer continues to be a top pick for investors.
Case Study: Pfizer's collaboration with BioNTech on the COVID-19 vaccine has been a game-changer. The vaccine received emergency use authorization from the FDA in December 2020 and has been instrumental in controlling the spread of the virus.
3. Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a leader in biopharmaceuticals and healthcare solutions. The company has a robust pipeline of new drugs and focuses on oncology, immunology, and cardiovascular diseases. Its commitment to innovation and global healthcare has made it a favorite among investors.
Case Study: In 2022, Merck acquired Acceleron Pharma, a biopharmaceutical company focused on the development of therapies for rare and serious diseases. This acquisition strengthened Merck's position in the rare disease market.
4. AbbVie Inc. (ABBV)
AbbVie Inc. is a global biopharmaceutical company known for its innovative therapies. The company's focus on immunology, virology, neuroscience, and metabolic diseases has made it a dominant player in the healthcare industry.
Case Study: AbbVie's drug, Humira, is the best-selling drug in the world. The drug has been approved for various conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease.
5. Amgen Inc. (AMGN)
Amgen Inc. is a leader in biotechnology and has a strong pipeline of new drugs. The company's focus on oncology, neuroscience, and cardiovascular diseases has made it a top pick for investors.
Case Study: In 2022, Amgen entered into a strategic collaboration with Novartis to develop and commercialize novel therapies for cancer. This partnership strengthens Amgen's position in the oncology market.
Investing in the healthcare sector can be a rewarding endeavor, especially when you choose the right stocks. As we look ahead to 2023, these top five US health stocks offer promising opportunities for investors. Keep an eye on these companies and stay informed about their latest developments to make informed investment decisions.
can foreigners buy us stocks
